Oncology
Sarat Chandarlapaty, M.D., PH.D.
Breast Medical Oncologist; Naddisy Foundation Chair in Breast Cancer Research at Memorial Sloan Kettering; Section Head for Translational Research, Breast Service, Department of Medicine; Director, Developmental Research Program, MSK Breast SPORE; Member and Lab Head, Human Oncology and Pathogenesis Program
Dr. Sarat Chandarlapaty is a board-certified medical oncologist specializing in breast cancer at Memorial Sloan Kettering Cancer Center (MSK) in New York, NY. His clinical practice focuses on treating patients with breast cancers and conditions, employing advanced techniques including antibody therapy, immunotherapy, and targeted therapies such as CDK4/6 inhibitors, PI3K inhibitors, and antibody-drug conjugates (ADCs). He manages aggressive forms of breast cancer, particularly those developing r
24+
Years in Practice
Credentials
Board Certifications
- Medical Oncology
- Internal Medicine
Education & Training
- Wake Forest University School of Medicine — M.D., 2002
- University of North Carolina at Chapel Hill — Ph.D., Biochemistry
- Memorial Sloan Kettering Cancer Center — Fellowship, Hematology & Oncology, 2005-2007
- New York Presbyterian Hospital — Residency, Internal Medicine, 2002-2005
Peer Recognition
2023-2025 (3 years)
- Castle Connolly — America's Top Doctor
2023-2026 (4 years)
2021-2025 (5 years)
Recognition & Leadership
Awards & Honors
- Castle Connolly: America's Top Doctor (2026)
- Castle Connolly: America's Top Doctor (2025)
- Castle Connolly: Top AAPI Doctor (2024)
- Castle Connolly: America's Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Memorial Sloan Kettering Cancer Center
Languages
English
Experience
24+ years in practice